Skip to content

The Effect of Laparoscopic Sleeve Gastrectomy on the Pharmacokinetics of Omeprazole Based on PPK/PBPK modeling

The Effect of Laparoscopic Sleeve Gastrectomy on the Pharmacokinetics of Omeprazole Based on PPK/PBPK modeling

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046578
Enrollment
Unknown
Registered
2021-05-22
Start date
2021-05-25
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic sleeve gastrectomy

Interventions

experimental group:Omeprazole

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Obese patients aged >=18 years, who underwent LSG surgery; 2.Omeprazole was orally administrated before and after surgery; 3.Sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients who use CYP2C19/3A4 inducers or inhibitors within 2 weeks of the trial.

Design outcomes

Primary

MeasureTime frame
Omeprazole plasma concentration;

Countries

China

Contacts

Public ContactPei Qi

The Third Xiangya Hosipital of Central South University

peiqi1028@126.com+86 13170419804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026